This company has shut down. PolyCore Therapeutics is no longer operating.
Explore the Startup GraveyardPolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
PolyCore Therapeutics's investors include National Institutes of Health, Ben Franklin Technology Partners of Southeastern Pennsylvania, Xontogeny.
PolyCore Therapeutics is headquartered in Philadelphia, United States.
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
PolyCore Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PolyCore Therapeutics — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/polycore-therapeutics. Accessed October 25, 2026.
VCBacked. (2022). PolyCore Therapeutics — Funding & Investors. Retrieved October 25, 2026, from https://www.vcbacked.co/company/polycore-therapeutics
{{cite web |title=PolyCore Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/polycore-therapeutics |website=VCBacked |access-date=October 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated